PharmaCyte Biotech, Inc.
PMCBNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $3.84M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.33$1.51
- Volume (live)
- -
- Avg. volume (3M)
- 305.25K
PharmaCyte Biotech (PMCB) Stock Price & Financial Analysis
PharmaCyte Biotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.34 - $0.36 |
|---|---|
| 52-Week High | $1.51 |
| 52-Week Low | $0.33 |
| Open | $0.35 |
| Volume (last close) | 33.00K |
| Average Volume (3M) | 305.25K |
| 50-Day MA | $0.47 |
|---|---|
| 200-Day MA | $0.67 |
| 1-Year Change | −63.13% |
| Market Cap | 3.84M |
|---|---|
| Shares Outstanding | 10.74M |
| Price to Book (P/B) | 0.13 |
| EV/EBITDA | 2.54 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
PharmaCyte Biotech at a Glance
As of the Oct 16, 2026 close, PharmaCyte Biotech (PMCB) has a market capitalization of $3.84M.
As of its latest reported balance sheet, it holds $17.74M in cash and securities against $0.00 of debt, a net cash position of $17.74M.
PharmaCyte Biotech does not currently pay a dividend.
The share price is down 63.1% over the past year. At $0.34 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.33 to $1.51, below its 200-day moving average of $0.67.
Frequently Asked Questions About PharmaCyte Biotech
What is the current stock price for PMCB?
As of the Oct 16, 2026 close, PMCB stock trades at $0.34. The 52-week range is $0.33–$1.51, with a day range of $0.34–$0.36.
What is the P/E ratio for PMCB?
The P/E ratio (Price-to-Earnings) for PMCB is shown in the Key Statistics section. This valuation metric helps compare PharmaCyte Biotech, Inc. to industry peers.
Does PMCB pay dividends?
PharmaCyte Biotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PMCB?
Analyst ratings and recommendations for PMCB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of PMCB?
As of the Oct 16, 2026 close, PharmaCyte Biotech's market capitalization is $3.7M, classifying it as a micro-cap company. PharmaCyte Biotech operates in the Healthcare sector within the Biotechnology industry.